 |
|
Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project
Stephen Havas, MD, MPH, MS;
Lauren Koumjian, MSc;
Joel Reisman, MS;
Lily Hsu, MS, RD;
Susan Wozenski, MPH, JD
JAMA. 1991;266(3):375-381.
Abstract
| |
Objective.
—To evaluate the effectiveness of a model blood cholesterol screening program.
Design.
—Principal components included physician education, communitybased screenings, and follow-up. A lay or professional educator provided counseling and referral advice. Half of the subjects with high blood cholesterol levels received a reminder to see their physician.
Setting.
—135 sites in four Massachusetts communities.
Participants.
—10 428 adults. Males, the young, the poor, the less educated, and minorities were underrepresented.
Main Outcome Measures.
—Referral completion rates, blood cholesterol changes.
Results.
—51.5% of those referred had visited their physicians within 2 to 4 months, increasing to 65.6% within 6 to 12 months. Older age (odds ratio [OR], 1.17 per additional decade), more education (OR, 1.17 per additional level), higher blood cholesterol levels (OR, 1.19 per additional 0.51 mmol/L), previous knowledge of level (OR, 1.34), and receiving a reminder (OR, 1.24) were significantly associated with greater likelihood of referral completion, whereas the type of educator providing counseling was not. Physicians had remeasured the blood cholesterol level of 76% of those seen, given dietary counseling to 70%, and prescribed medication to 15%. Significant changes in dietary fat were reported by both compliers and noncompliers with advice to follow up with their physicians. Six months after screening, blood cholesterol levels were 3.6% lower in noncompliers, 4.4% lower in compliers not taking cholesterol-lowering medications, and 8.8% in compliers taking such medications.
Conclusions.
—An effective, community-based blood cholesterol screening program can attract diverse populations and can result in most participants with high levels following up with their physicians, making dietary changes, and lowering their cholesterol levels. Additional strategies may be needed to attract underrepresented groups and to reduce the apparent overuse of cholesterollowering medications.
(JAMA. 1991;266:375-381)
Author Affiliations
From the Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore (Dr Havas); the Massachusetts Department of Public Health, Boston (Dr Havas, Mss Koumjian and Hsu, and Mr Reisman); and the College of Health Professions, University of Lowell (Mass) (Dr Wozenski).
Footnotes
Reprint requests to Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 655 W Baltimore St, Baltimore, MD 21201 (Dr Havas).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Do Persons With Diabetes Know Their (AIC) Number?
Harwell et al.
The Diabetes Educator 2002;28:99-105.
ABSTRACT
Evaluating Cholesterol Screening: The Importance of Controlling for Regression to the Mean
Forrow et al.
Arch Intern Med 1995;155:2177-2184.
ABSTRACT
An Experimental Evaluation of an Incentive Program to Reduce Serum Cholesterol Levels Among Health Fair Participants
Francisco et al.
Arch Fam Med 1994;3:246-251.
ABSTRACT
Some Cautions in Labeling Effects
Havas
Arch Intern Med 1992;152:202-202.
ABSTRACT
Cholesterol Screening: Hits and Misses
Record and Record
JAMA 1991;266:2701-2701.
ABSTRACT
|
